AJICAP Second Generation: Improved Chemical Site-Specific Conjugation Technology for Antibody–Drug Conjugate ProductionTomohiro Fujii, Kei Yamada, Sayaka Kawaguchi et al.|Bioconjugate Chemistry|2023Cited by 62
Exo-Cleavable Linkers: Enhanced Stability and Therapeutic Efficacy in Antibody–Drug ConjugatesTomohiro Watanabe, Yutaka Matsuda, Naoko Arashida et al.|Journal of Medicinal Chemistry|2024Cited by 58
AJICAP Second Generation: Improved Chemical Site-Specific Conjugation Technology for Antibody-Drug Conjugate ProductionTomohiro Fujii, Kei Yamada, Yutaka Matsuda et al.|ChemRxiv|2023Cited by 20
Exo-Cleavable Linkers: A Paradigm Shift for Enhanced Stability and Therapeutic Efficacy in Antibody-Drug ConjugatesTomohiro Watanabe, Yutaka Matsuda, Naoko Arashida et al.|ChemRxiv|2023Cited by 4